Dec Group has entered into a strategic financial partnership with ICG to enhance its growth strategy in high-containment processing technologies within the pharmaceutical sector.
Target Company Information
Dec Group is a prominent global leader specializing in high-containment processing technologies within the pharmaceutical, chemical, and specialty industries. The company has earned a solid reputation for its innovative solutions that enhance safety and efficiency in handling high-risk materials. Dec Group focuses on delivering custom-designed powder handling systems tailored primarily for the pharmaceutical sector, facilitating safer and more hygienic transport of hazardous and explosive powders.
With nearly 25 years of experience in the field, Dec Group has consistently demonstrated its commitment to product innovation, expanding its reach across various markets. The recent strategic partnership with ICG is intended to bolster Dec's ambitious growth strategy, which encompasses geographic expansion, product enhancement, and penetration into promising end-markets.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in Switzerland
The pharmaceutical industry in Switzerland ranks among the most advanced in the world, characterized by a strong emphasis on innovation and research and development. Switzerland is home to some of the largest global pharmaceutical corporations and numer
Similar Deals
Alexander Square Partners → Essential Pharma
2024
Zhongtian Biotech → Unified Biotech
2024
capiton V
invested in
Dec Group
in 2025
in a Other Private Equity deal